Table 1 Patient characteristics.
IND-CHTN Retrospective Cohort | Multi-Hospital Prospective Cohort | |
|---|---|---|
No of patients | 413 | 243 |
Median age (Q1, Q3) | 65 (61, 68) | 70 (64, 76) |
ISUP/Gleason grade group (%) | ||
Group 1: ≤6 ( ≤ 3 + 3) | 76 (18%) | 56 (23%) |
Group 2: 7 (3 + 4) | 197 (48%) | 47 (19%) |
Group 3: 7 (4 + 3) | 113 (27%) | 63 (26%) |
Group 4: 8 (4 + 4, 3 + 5, 5 + 3) | 9 (2%) | 43 (18%) |
Group 5: 9 or 10 (4 + 5, 5 + 4, or 5 + 5) | 18 (4%) | 34 (14%) |
Pre-operative PSA (%) | ||
PSA < 10 ng/dL | 0 | 84 (35%) |
PSA 10-20 ng/dL | 0 | 53 (22%) |
PSA > 20 ng/dL | 0 | 104 (43%) |
PSA unknown | 413 (100%) | 2 (0.8%) |
Pelvic lymph node metastasis (%) | 20 (5%) | 35 (14%) |
Median number of lymph nodes dissected (Q1, Q3) | 6 (4, 10) | 13 (9, 15) |
Distant metastasis (%) | 9 (2%) | 76 (31%) |
BCR (%) | 42 (10%) | - |
Cancer risk (%) | ||
Low risk | 42 (10%) | 29 (12%) |
High risk | 371 (90%) | 214 (88%) |
